|
Wang, X; Luo, W; Foon, K A et al. (2001) Tumor associated antigen (TAA) mimicry and immunotherapy of malignant diseases from anti-idiotypic antibodies to peptide mimics. Cancer Chemother Biol Response Modif 19:309-26
|
|
Ferrone, S; Wang, X (2001) Active specific immunotherapy of malignant melanoma and peptide mimics of the human high-molecular-weight melanoma-associated antigen. Recent Results Cancer Res 158:231-5
|
|
Kageshita, T; Hamby, C V; Hirai, S et al. (2000) Differential clinical significance of alpha(v)Beta(3) expression in primary lesions of acral lentiginous melanoma and of other melanoma histotypes. Int J Cancer 89:153-9
|
|
Kageshita, T; Hamby, C V; Hirai, S et al. (2000) Alpha(v)beta3 expression on blood vessels and melanoma cells in primary lesions: differential association with tumor progression and clinical prognosis. Cancer Immunol Immunother 49:314-8
|
|
Marincola, F M; Jaffee, E M; Hicklin, D J et al. (2000) Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv Immunol 74:181-273
|
|
Wang, X; Luo, W; Ferrone, S (2000) Immunotherapy of melanoma: peptide mimics of a human high molecular weight-melanoma associated antigen. Medicina (B Aires) 60 Suppl 2:48-50
|
|
Perosa, F; Luccarelli, G; Prete, M et al. (1999) Increased serum levels of beta2m-free HLA class I heavy chain in multiple myeloma. Br J Haematol 106:987-94
|
|
Hicklin, D J; Marincola, F M; Ferrone, S (1999) HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story. Mol Med Today 5:178-86
|
|
Kageshita, T; Hirai, S; Ono, T et al. (1999) Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression. Am J Pathol 154:745-54
|
|
Willers, J; Lucchese, A; Kanduc, D et al. (1999) Molecular mimicry of phage displayed peptides mimicking GD3 ganglioside. Peptides 20:1021-6
|
Showing the most recent 10 out of 42 publications
